Home › Free Stock Grades › SRZN
Surrozen, Inc. (SRZN) Stock Grade
SRZN · Healthcare
D+
Market Cap
$221.6M
P/E Ratio
—
Revenue Growth (YoY)
-67.4%
Net Margin
-6960.8%
Return on Equity
128.9%
Dividend Yield
None
About Surrozen, Inc.'s fundamentals
Surrozen is a biotechnology company with a market capitalization of $221.6 million that reported significant financial headwinds in its most recent period, including a 67.4% year-over-year decline in revenue and a net loss resulting in a negative net margin of -6960.8%. The company does not currently pay a dividend. While the company's return on equity metric stands at 128.9%, this figure should be interpreted cautiously given the company's unprofitable operations and the distortions that can occur in ROE calculations during loss-making periods.